Screening and diagnosis

Classification and risk stratification

Perioperative care

Quality improvement

Patient education

Nonpharmacologic interventions

Therapeutic procedures

Respiratory support

Follow-up and surveillance

Specific circumstances

Preventative measures

Medical management

Surgical interventions

Inpatient care

Diagnostic procedures

Diagnostic investigations

Insufficient evidence to make a recommendation.

Strongly favor this test or intervention.

The TNM classification calculator evaluates duodenal neuroendocrine tumors by assessing three critical parameters: the tumor classification, the lymph node involvement, and the presence of distant metastasis. Each category offers specific options corresponding to the tumor's characteristics, spreading potential, and metastasis involvement.

Input categories and their classifications:

1. Tumor Classification:
   - Tx: The primary tumor cannot be assessed
   - T0: No evidence of the primary tumor
   - T1: The tumor is 1 cm or smaller and invades only the mucosa or submucosa; applicable to ampullary tumors confined within the sphincter of Oddi
   - T2: The tumor exceeds 1 cm or invades the muscularis propria for duodenal tumors
   - T3: The tumor invades the pancreas or peripancreatic adipose tissue
   - T4: The tumor invades visceral peritoneum or other organs

2. Lymph Node Classification:
   - Nx: Regional lymph nodes cannot be assessed
   - N0: No regional lymph node metastasis
   - N1: Regional lymph nodes present with metastases

3. Distant Metastasis:
   - M0: No distant metastasis detected
   - M1a: Metastasis is confined to the liver
   - M1b: Metastases present at one or more extrahepatic sites, such as the lung, ovary, non-regional lymph nodes, peritoneum, and bone
   - M1c: Metastases present in both hepatic and extrahepatic sites

The interpretation of this data is performed via logical conditions that match specific combinations of the tumor classification, lymph node classification, and the presence or absence of distant metastasis, resulting in a stage designation according to the complexity and spread of the tumor.

Key logic-based determinations used in the computation:

- If a tumor is classified as T1, with no regional lymph node involvement (N0) and no distant metastasis (M0), the tumor stage is deemed Stage I.
- Tumors classified as T2 or T3, absent regional lymph node metastasis (N0), and absent distant metastasis (M0), are assigned Stage II.
- Stage III status occurs if there is either a T4 classification with no regional lymph node metastasis (N0) and absence of distant metastasis (M0), or any T classification with regional lymph node metastases (N1) and no distant metastasis (M0).
- Stage IV encompasses any tumor classification (T1 to T4) with either regional lymph node presence (N0 or N1) and any distant metastasis classification (M1a, M1b, or M1c).

The calculator in question is the TNM Classification for Duodenal Neuroendocrine Tumors. TNM stands for Tumor, Node, Metastasis, a system used to classify malignant tumors. This specific TNM classification is applicable to patients diagnosed with neuroendocrine tumors in the duodenum, a part of the small intestine.

The clinical utility of this calculator is to stage the cancer, which helps in determining the severity or extent of the cancer in the body. It provides valuable information about the size of the primary tumor (T), whether the cancer has spread to the lymph nodes (N), and the presence of distant metastasis (M). This information is crucial in planning the treatment strategy and predicting the patient's prognosis.

There are no specific exclusion criteria for the use of the TNM Classification for Duodenal Neuroendocrine Tumors. However, it is not applicable to patients with neuroendocrine tumors located in other parts of the body or to those with non-neuroendocrine tumors.

TNM classification for duodenal neuroendocrine tumors

The TNM classification system for jejunoileal neuroendocrine tumors uses three key classifications to determine the stage of the tumor: tumor classification, lymph node classification, and distant metastasis. Users provide their selections among specific predefined options for each category. Based on these selections, the system computes the tumor stage using established criteria.

For tumor classification, the options include:

- Tx: Primary tumor cannot be assessed
- T0: No evidence of primary tumor
- T1: Tumor less than or equal to 1 cm and invades lamina propria or submucosa
- T2: Tumor greater than 1 cm or invades muscularis propria
- T3: Tumor invades through muscularis propria into subserosal tissue without penetration of the overlying serosa
- T4: Tumor invades visceral peritoneum or other organs or adjacent structures

Lymph node assessment options are:

- Nx: Regional lymph nodes cannot be assessed
- N0: No regional lymph node metastasis
- N1: Regional lymph node metastases in fewer than 12 nodes
- N2: Large mesenteric masses (more than 2 cm) and/or extensive nodal deposits (12 or more), especially encasing superior mesenteric vessels

Finally, distant metastasis options include:

- M0: No distant metastasis
- M1a: Metastasis confined to the liver
- M1b: Metastases in one or more extrahepatic sites, such as the lung, ovary, nonregional lymph node, peritoneum, and bone
- M1c: Metastases in both hepatic and extrahepatic sites

The system then applies a logic to map combinations of these selections to specific cancer stages:

- Stage I is identified when the selections are T1, N0, and M0.
- Stage II is determined by T2 or T3, combined with N0 and M0.
- Stage III encapsulates conditions where selections meet one of these patterns:
  - Tumor classifications T1, T2, or T3 with lymph node classifications N1 or N2, and M0.
  - A tumor classified as T4 with any lymph node classification and M0.
- Stage IV is assigned when any tumor classification (T1 through T4) with any lymph node classification and distant metastasis (M1a, M1b, or M1c) are selected.

Using these combinations, the TNM classification system effectively interprets and provides a stage designation for jejunoileal neuroendocrine tumors, guiding clinical decision-making by carefully considering tumor size, location, lymph node involvement, and metastasis status.

The calculator in question is the TNM Classification for Jejunoileal Neuroendocrine Tumors. TNM stands for Tumor, Node, Metastasis. This classification system is used by clinicians to stage jejunoileal neuroendocrine tumors, which are a type of cancer that occurs in the jejunum and ileum parts of the small intestine.

The TNM Classification for Jejunoileal Neuroendocrine Tumors is applicable to patients who have been diagnosed with this specific type of cancer. It helps in determining the extent of cancer spread, which is crucial for planning the appropriate treatment strategy and predicting patient prognosis.

The clinical utility of this calculator lies in its ability to provide a standardized language for reporting and staging cancer, which facilitates communication among healthcare providers and allows for more accurate prediction of patient outcomes.

There are no specific exclusion criteria for the use of the TNM Classification for Jejunoileal Neuroendocrine Tumors. However, it should be noted that this system is not applicable to other types of cancers or tumors located in other parts of the body. It is also less useful in early-stage cancers where the disease has not yet spread beyond the primary site.

Small bowel neuroendocrine tumors

Guidelines

Key sources